These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24401336)

  • 21. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in medicinal chemistry 2004.
    Armer RE; Cowley PM
    Drug News Perspect; 2005 Mar; 18(2):142-8. PubMed ID: 15883623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interscience Conference on Antimicrobial Agents and Chemotherapy - 50th Annual Meeting - Research on Promising New Agents: Part 2.
    Walker K
    IDrugs; 2010 Nov; 13(11):746-8. PubMed ID: 21046516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
    Thakur K; Sharma G; Singh B; Katare OP
    Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global medicinal chemistry and GCPR conference.
    Schio L
    Future Med Chem; 2018 Jun; 10(11):1287-1288. PubMed ID: 29719974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal antibiotics for the treatment of infectious diseases.
    Alhariri M; Azghani A; Omri A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery.
    Haselbeck R; Wall D; Jiang B; Ketela T; Zyskind J; Bussey H; Foulkes JG; Roemer T
    Curr Pharm Des; 2002; 8(13):1155-72. PubMed ID: 12052225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neglected tropical diseases and infectious illnesses: potential targeted peptides employed as hits compounds in drug design.
    Silva JV; Santos SDS; Machini MT; Giarolla J
    J Drug Target; 2021 Mar; 29(3):269-283. PubMed ID: 33059502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming biological peptides to combat infectious diseases.
    Der Torossian Torres M; de la Fuente-Nunez C
    Chem Commun (Camb); 2019 Dec; 55(100):15020-15032. PubMed ID: 31782426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug development.
    Williams I
    Science; 1997 Jul; 277(5322):20. PubMed ID: 9229763
    [No Abstract]   [Full Text] [Related]  

  • 31. Heat shock protein 90 inhibitors as broad spectrum anti-infectives.
    Rochani AK; Singh M; Tatu U
    Curr Pharm Des; 2013; 19(3):377-86. PubMed ID: 22920905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host-directed drug targeting of factors hijacked by pathogens.
    Schwegmann A; Brombacher F
    Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases.
    Duval MX
    Exp Biol Med (Maywood); 2018 Aug; 243(12):1004-1013. PubMed ID: 30089398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deubiquitinating enzymes as promising drug targets for infectious diseases.
    Nanduri B; Suvarnapunya AE; Venkatesan M; Edelmann MJ
    Curr Pharm Des; 2013; 19(18):3234-47. PubMed ID: 23151130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Antimicrobial Approaches: Reuse of Old Drugs.
    Savoia D
    Curr Drug Targets; 2016; 17(6):731-8. PubMed ID: 26245476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of genomics on discovering drugs against infectious diseases.
    Boshoff HI; Manjunatha UH
    Microbes Infect; 2006 May; 8(6):1654-61. PubMed ID: 16690340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
    Tse-Dinh YC
    Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics.
    Rachakonda S; Cartee L
    Curr Med Chem; 2004 Mar; 11(6):775-93. PubMed ID: 15032731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS).
    Le Grice SF; Sztuba-Solinska J; Maccioni E; Purzycka KJ; Parolin C; Tramontano E
    Antiviral Res; 2017 Mar; 139():13-17. PubMed ID: 27939841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.